PsyBio Therapeutics Corp. (PSYBF)
USD 0.0
(-98.0%)
USD 0.0
(-98.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -4.88 Million USD | 55.66% |
| 2021 | -11.01 Million USD | -71.22% |
| 2020 | -6.43 Million USD | -39729.54% |
| 2019 | -16.15 Thousand USD | 22.54% |
| 2018 | -20.86 Thousand USD | 47.65% |
| 2017 | -39.85 Thousand USD | 29.91% |
| 2016 | -56.86 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -811.49 Thousand USD | 13.82% |
| 2023 Q2 | -181.99 Thousand USD | 77.57% |
| 2022 Q2 | -1.43 Million USD | 9.34% |
| 2022 Q4 | -941.64 Thousand USD | -2.14% |
| 2022 FY | -4.88 Million USD | 55.66% |
| 2022 Q1 | -1.58 Million USD | 35.22% |
| 2022 Q3 | -921.89 Thousand USD | 35.86% |
| 2021 FY | -11.01 Million USD | -71.22% |
| 2021 Q1 | -2.59 Million USD | -3031.55% |
| 2021 Q2 | -3.84 Million USD | -47.88% |
| 2021 Q3 | -2.29 Million USD | 40.2% |
| 2021 Q4 | -2.44 Million USD | -6.54% |
| 2020 Q2 | -1709.25 USD | -72.3% |
| 2020 FY | -6.43 Million USD | -39729.54% |
| 2020 Q4 | -82.92 Thousand CAD | 87.12% |
| 2020 Q3 | -643.94 Thousand USD | -37574.14% |
| 2020 Q1 | -992.03 USD | 90.6% |
| 2019 Q4 | -10.55 Thousand CAD | 0.0% |
| 2019 FY | -16.15 Thousand USD | 22.54% |
| 2018 FY | -20.86 Thousand USD | 47.65% |
| 2017 FY | -39.85 Thousand USD | 29.91% |
| 2016 FY | -56.86 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -265.879% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 30.028% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 109.223% |
| Nascent Biotech, Inc. | -2.08 Million USD | -134.042% |
| Rebus Holdings, Inc. | -1.02 Million USD | -379.026% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 107.502% |
| Qrons Inc. | -789.34 Thousand USD | -519.001% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -672.614% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 92.195% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1076.007% |
| Skye Bioscience, Inc. | -37.64 Million USD | 87.021% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 93.482% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 25.7% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1687.135% |
| SQZ Biotechnologies Company | -79.46 Million USD | 93.851% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -68.928% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -168.387% |
| Mesoblast Limited | -87.95 Million USD | 94.445% |
| Marizyme, Inc. | -65.34 Million USD | 92.523% |
| Genus plc | 7.9 Million USD | 161.849% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 55.14% |
| Pharming Group N.V. | -10.54 Million USD | 53.678% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -125.183% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -31.692% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 44.753% |
| ContraFect Corporation | -65.15 Million USD | 92.501% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -182.847% |
| IMV Inc. | -36.48 Million USD | 86.608% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 39.376% |
| MultiCell Technologies, Inc. | -380.07 USD | -1285469.237% |
| ONE Bio Corp. | 8.67 Million USD | 156.313% |
| Accustem Sciences Inc. | -3.74 Million USD | -30.42% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 90.548% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -285.6% |
| Q BioMed Inc. | -2.05 Million USD | -138.101% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -30.888% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -105.222% |
| Biomind Labs Inc. | -1.21 Million USD | -302.371% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 91.819% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -57.525% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 38.175% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -150.664% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -32525.955% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 69.215% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 16.007% |
| GB Sciences, Inc. | -1.36 Million USD | -258.827% |
| Alpha Cognition Inc. | -13.77 Million USD | 64.523% |
| HST Global, Inc. | -146.21 Thousand USD | -3241.812% |
| CSL Limited | 2.64 Billion USD | 100.185% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -178.444% |
| Halberd Corporation | -79.67 Thousand USD | -6032.415% |
| Enzolytics Inc. | -2.17 Million USD | -124.458% |
| Agentix Corp. | -1.37 Million USD | -255.554% |
| Resverlogix Corp. | -3.61 Million USD | -35.348% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -54.065% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 98.344% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 5085.779% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 170.561% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -22.982% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -61.462% |
| AVAX Technologies, Inc. | -6.41 Million USD | 23.818% |
| Zenith Capital Corp. | -10.59 Million USD | 53.888% |
| Genscript Biotech Corporation | -95.47 Million USD | 94.882% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -20922.558% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -17.852% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -7984.073% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -143.68% |
| Kadimastem Ltd | -3.3 Million USD | -47.731% |
| Helix BioMedix, Inc. | -1.05 Million USD | -362.67% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -27.941% |
| BioStem Technologies, Inc. | -8.48 Million USD | 42.402% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -1007.025% |
| LadRx Corporation | 400.44 Thousand USD | 1320.164% |
| Cell Source, Inc. | -5.32 Million USD | 8.178% |
| Regen BioPharma, Inc. | 1.02 Million USD | 577.384% |
| Regen BioPharma, Inc. | 1.02 Million USD | 577.384% |
| NovAccess Global Inc. | -4.76 Million USD | -2.451% |
| Affymax, Inc. | -14.42 Million USD | 66.125% |
| Itoco Inc. | -1.86 Million USD | -161.427% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -9.984% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -192.754% |
| Mobile Lads Corp. | -2.26 Million USD | -115.883% |
| CytoDyn Inc. | -49.84 Million USD | 90.197% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -6082.307% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -2041.817% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -418.95% |
| SYBLEU INC | -180.3 Thousand USD | -2609.903% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -202.967% |
| International Stem Cell Corporation | -131 Thousand USD | -3629.819% |
| Bioxytran, Inc. | -4.28 Million USD | -14.16% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -8902.917% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -93.106% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 89.836% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -131.129% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -525.707% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -54.232% |
| Neutra Corp. | -233.46 Thousand USD | -1992.846% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 75.92% |
| PureTech Health plc | -65.69 Million USD | 92.563% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 77.025% |
| IXICO plc | -1.17 Million USD | -314.776% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 50.78% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 91.447% |
| CSL Limited | 2.64 Billion USD | 100.185% |
| Cellectis S.A. | -103.17 Million USD | 95.264% |